Results 281 to 290 of about 2,123,410 (338)
Age Standardization of Epidemiological Frequency Measures: Part 37 of a Series on the Evaluation of Scientific Publications. [PDF]
Stang A, Gianicolo E.
europepmc +1 more source
Objective We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). Methods Three adipokines (adiponectin, leptin, and fibroblast growth factor [FGF]‐21) were measured using banked enrollment serum from participants in a longitudinal RA cohort.
Joshua F. Baker +9 more
wiley +1 more source
Aligning with regulatory agencies for the use of digital health technologies in drug development: a case study from Parkinson's disease. [PDF]
Hill DL +3 more
europepmc +1 more source
Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. Although pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen +4 more
wiley +1 more source
Why and When You Should Avoid Using z-scores in Graphs Displaying Profile or Group Differences. [PDF]
Moeller J.
europepmc +1 more source
Objective Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate‐lowering therapy in people with asymptomatic hyperuricemia. Methods Participants in a multinational study of
Nicola Dalbeth +19 more
wiley +1 more source
Avoiding leakage when classifying drought stress from OJIP fluorescence - comment on Xia <i>et al</i>. (2025). [PDF]
Pastore EP.
europepmc +1 more source
Objectives This study aimed to identify the frequency and determinants of Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS‐remission) attainment in systemic lupus erythematosus (SLE) patients with clinically active disease, and the frequency and determinants of flare and damage accrual after target attainment.
Yanjie Hao +39 more
wiley +1 more source
Biological Mechanisms and Clinical Challenges of Platelet-Rich Plasma in Chronic Musculoskeletal Pain: From Standardized Preparation to Multi-Omics-Guided Precision Therapy. [PDF]
Zhou H +4 more
europepmc +1 more source

